Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
Edited Transcript of LMAT earnings conference call or presentation 30-Apr-20 9:00pm GMT
05:27am, Friday, 01'st May 2020
Q1 2020 LeMaitre Vascular Inc Earnings Call
LeMaitre Vascular (LMAT) Meets Q1 Earnings Estimates
12:25am, Friday, 01'st May 2020
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -2.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Vascular (LMAT) Meets Q1 Earnings Estimates
12:25am, Friday, 01'st May 2020
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -2.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre: 1Q Earnings Snapshot
11:18pm, Thursday, 30'th Apr 2020
BURLINGTON, Mass. (AP) _ LeMaitre Vascular Inc. (LMAT) on Thursday reported first-quarter profit of $3.2 million. On a per-share basis, the Burlington, Massachusetts-based company said it had net inco
LeMaitre: 1Q Earnings Snapshot
11:17pm, Thursday, 30'th Apr 2020
BURLINGTON, Mass. (AP) _ LeMaitre Vascular Inc. (LMAT) on Thursday reported first-quarter profit of $3.2 million.
On a per-share basis, the Burlington, Massachusetts-based company said it had net inco
LeMaitre Vascular Q1 EPS $0.160 Beats $0.150 Estimate, Sales $30.551M Beat $30.300M Estimate
08:07pm, Thursday, 30'th Apr 2020LeMaitre Vascular Announces Q1 2020 Financial Results
08:05pm, Thursday, 30'th Apr 2020
BURLINGTON, Mass., April 30, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced.
LeMaitre Vascular Announces Q1 2020 Financial Results
08:05pm, Thursday, 30'th Apr 2020
BURLINGTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today...
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
Copeland Capital Management LLC Raises Stock Holdings in LeMaitre Vascular Inc (NASDAQ:LMAT)
10:22am, Thursday, 30'th Apr 2020
Copeland Capital Management LLC increased its holdings in shares of LeMaitre Vascular Inc (NASDAQ:LMAT) by 9.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
Notable earnings after Thursday's close
09:35pm, Wednesday, 29'th Apr 2020
AAPL, AEM, AJG, ALEX, AMGN, AMZN, ASGN, ATR, ATUS, BAND, BL, BLDR, BRKS, CDNA, CLGX, COG, COLM, CRY, CUZ, CXO, CXP, EBS, EGP, EIX, EMN, EXPO, FBHS, FHI, FMBI, FND, FTAI, FTV, FWRD, GILD, GLPI, HP, HTH
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to Buy by Zacks Investment Research
08:42am, Wednesday, 29'th Apr 2020
LeMaitre Vascular (NASDAQ:LMAT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Zacks.com re
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Buy" by BidaskClub
06:32am, Saturday, 25'th Apr 2020
BidaskClub upgraded shares of LeMaitre Vascular (NASDAQ:LMAT) from a hold rating to a buy rating in a report released on Tuesday morning, BidAskClub reports. LMAT has been the subject of several other
